Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

Charles River Laboratories International (CRL)

(Delayed Data from NYSE)

$206.58 USD

-0.77 (-0.37%)

Updated Jun 28, 2024 04:00 PM ET

After-Market: $206.64 +0.06 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.08%
2	Buy	17.91%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.55%
S&P	500	11.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

Top 35% (86 out of 249)

Industry: Medical Services

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

View Cart/Checkout

Charles River Laboratories International, Inc. [CRL]

Reports for Purchase

Showing records 121 - 140 ( 384 total )

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 121

04/01/2022

Pages: 16

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 122

03/22/2022

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 123

03/11/2022

Pages: 3

Transferring Coverage of 5 Companies, Suspending Coverage of 16 Companies, Terminating Coverage of 1 Company

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 124

03/08/2022

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 125

03/01/2022

Pages: 24

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 126

02/21/2022

Pages: 24

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 127

02/21/2022

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 128

02/16/2022

Pages: 6

What''s the Problem?

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 129

02/16/2022

Pages: 11

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 130

02/11/2022

Pages: 24

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 131

02/03/2022

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 132

02/01/2022

Pages: 24

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 133

01/24/2022

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 134

01/21/2022

Pages: 24

Comprehensive Technical and Fundamental Analysis for CRL.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 135

01/19/2022

Pages: 7

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 136

01/19/2022

Pages: 3

Charles River Continues to "Dip Its Toes" into Artificial Intelligence and Machine Learning

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 5.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 137

01/14/2022

Industry Report

Pages: 37

Healthcare Information Technology, Digital Health, and Biopharma Services (CROs)

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 35.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 138

01/11/2022

Pages: 3

Formal 2022 Guidance; CFO Transition

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 5.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 139

01/11/2022

Pages: 5

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 140

01/11/2022

Pages: 5

Updated Clarity on 2022

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 5.00

Research Provided by a Third Party

previous
1
2
4
5
6
7
8
9
10
...
19
20
next